Alzheimer drugs halted
Savings to go to Alzheimer care services
27 June 2018
By Connexion journalistFour Alzheimer drugs costing the health service €90million a year will no longer be reimbursed as the ministry moves to stop them being prescribed due to harmful side effects, which include falls and broken bones.
Savings on Aricept, Ebixa, Exelon, Reminyl and generics will go to Alzheimer care services.
More from French news
More from Connexion
Resident or second-home owner in France?
Benefit from our daily digest of headlines and how-to's to help you make the most of life in France
By joining the newsletter, you agree to our Terms & Conditions and Privacy Policy
1
10 million in France benefit from free glasses and dental work scheme
2 days ago2
Ten key changes and updates for residents in France in February 2022
1 day ago3
Why are Covid cases in France still higher than in most of Europe?
4 days ago4
France had 60 confirmed cases of BA.2 Covid subvariant last week
3 days ago5
Covid-19: Rules for travel to and from France
10 hours agoSee more popular articles
The Connexion Help Guides
Brexit and Beyond for Britons in France*
Inheritance Law and Wills in France* 
Editor's Picks
500,000 daily Covid cases in France: is going out a key reason why?
26 January 2022
Join the 10th edition of France’s winter bird count this weekend
28 January 2022
France’s new animal welfare law passes: What will it change for pets?
19 November 2021
Video: driver in 80s ends up with car on red ski run in east France
26 January 2022
Who still has to pay the taxe d’habitation in France in 2022?
22 January 2022
More from French news
More from Connexion
Get news, views and information from France
